PLRX - Pliant Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PLRX is currently covered by 9 analysts with an average price target of $18.95. This is a potential upside of $17.66 (1368.99%) from yesterday's end of day stock price of $1.29.

Pliant Therapeutics 's activity chart (see below) currently has 54 price targets and 88 ratings on display. The stock rating distribution of PLRX is 79.25% BUY and 20.75% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 13.47% with an average time for these price targets to be met of 62 days.

Highest price target for PLRX is $10, Lowest price target is $1.5, average price target is $17.08.

Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 18-Mar-2025. First documented stock forecast 29-Jun-2020.

Currently out of the existing stock ratings of PLRX, 42 are a BUY (79.25%), 11 are a HOLD (20.75%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

2 months 6 days ago
(18-Mar-2025)

0/19 (0%)

$23 (153.33%)

Hold

2 months 20 days ago
(04-Mar-2025)

1/5 (20%)

$45.98 (270.15%)

199

Hold

$3

$1.71 (132.56%)

$4

2 months 20 days ago
(04-Mar-2025)

0/14 (0%)

$1.62 (117.39%)

Hold

$1.5

$0.21 (16.28%)

$4

2 months 20 days ago
(04-Mar-2025)

2/6 (33.33%)

$0.12 (8.70%)

74

Buy

$10

$8.71 (675.19%)

$10

2 months 20 days ago
(04-Mar-2025)

0/14 (0%)

$8.62 (624.64%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PLRX (Pliant Therapeutics ) average time for price targets to be met?

On average it took 62 days on average for the stock forecasts to be realized with a an average price target met ratio 13.47

Which analyst has the current highest performing score on PLRX (Pliant Therapeutics ) with a proven track record?

DAVID LEBOWITZ

Which analyst has the most public recommendations on PLRX (Pliant Therapeutics )?

David Lebowitz works at CITI and has 10 price targets and 12 ratings on PLRX

Which analyst is the currently most bullish on PLRX (Pliant Therapeutics )?

Joel Beatty with highest potential upside - $42.71

Which analyst is the currently most reserved on PLRX (Pliant Therapeutics )?

Pete Stavropoulos with lowest potential downside - -$0

Pliant Therapeutics  in the News

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations

–  Implementation of cost reduction initiatives to position Pliant for execution of late-stage clinical trials –  Pliant will reduce its current workforce by approximately 45% –  Closing activities for BEACON-IPF trial ongoing; topline data expected in the second quarter of 2025 SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq:...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?